Newsroom
Monarch Technologies receives CHF 40,000 from Venture Kick to accelerate validation toward clinical translation
16.06.2026
Monarch Technologies receives CHF 40,000 from Venture Kick to advance its adaptive drug delivery platform for locoregional cancer therapies. By dynamically overcoming biological barriers during treatment, the technology enhances drug delive ... mehr
SonoStent receives CHF 40,000 from Venture Kick to advance non-invasive urinary stent technology
16.06.2026
SonoStent receives CHF 40,000 from Venture Kick to advance its ultrasound-activated technology for urinary stents and catheters. By removing biofilm and encrustation without requiring device removal, the solution aims to reduce repeated sur ... mehr
Immitra Bio receives CHF 150,000 from Venture Kick to reimagine stem cell therapy for rare diseases
15.06.2026
The ETH spin-off Immitra Bio has received CHF 150,000 from Venture Kick to develop a new treatment approach for rare genetic diseases. The biotech startup aims to replace complex stem cell transplantation procedures with a single injection, ... mehr
Newsletter Archiv
Momentum Beyond the Lab 🧪
Spring momentum across Swiss startups 🌱
A record 2025, and kicking bigger in 2026! 🚀
Medienmitteilungen
Presseschau
1000 Unternehmen mit Venture Kick gegründet
Medienanfragen
Für Presseanfragen, schreiben Sie bitte unserem Kommunikationsteam. Falls Sie generelle Fragen zu Venture Kick haben, gehen Sie bitte auf unsere Kontaktseite.
Erfahren Sie mehr über Venture Kick oder laden Sie sich unseren letzten Jahresbericht herunter für detaillierte Informationen.